- Home
- BGSF vs CRVO Comparison
BGSF vs CRVO Comparison
Compare BGSF & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGSF
- CRVO
- Stock Information
- Founded
- BGSF 2007
- CRVO 2001
- Country
- BGSF United States
- CRVO United States
- Employees
- BGSF N/A
- CRVO N/A
- Industry
- BGSF Professional Services
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- BGSF Consumer Discretionary
- CRVO Health Care
- Exchange
- BGSF Nasdaq
- CRVO Nasdaq
- Market Cap
- BGSF 70.1M
- CRVO 67.4M
- IPO Year
- BGSF N/A
- CRVO N/A
- Fundamental
- Price
- BGSF $7.07
- CRVO $7.79
- Analyst Decision
- BGSF Strong Buy
- CRVO Strong Buy
- Analyst Count
- BGSF 1
- CRVO 6
- Target Price
- BGSF $9.00
- CRVO $19.17
- AVG Volume (30 Days)
- BGSF 408.1K
- CRVO 109.2K
- Earning Date
- BGSF 11-05-2025
- CRVO 11-11-2025
- Dividend Yield
- BGSF N/A
- CRVO N/A
- EPS Growth
- BGSF N/A
- CRVO N/A
- EPS
- BGSF N/A
- CRVO N/A
- Revenue
- BGSF $266,615,000.00
- CRVO $7,776,968.00
- Revenue This Year
- BGSF N/A
- CRVO N/A
- Revenue Next Year
- BGSF N/A
- CRVO N/A
- P/E Ratio
- BGSF N/A
- CRVO N/A
- Revenue Growth
- BGSF 28.60
- CRVO N/A
- 52 Week Low
- BGSF $2.91
- CRVO $1.80
- 52 Week High
- BGSF $9.06
- CRVO $19.50
- Technical
- Relative Strength Index (RSI)
- BGSF 59.80
- CRVO 33.57
- Support Level
- BGSF $6.36
- CRVO $9.61
- Resistance Level
- BGSF $8.22
- CRVO $10.48
- Average True Range (ATR)
- BGSF 0.32
- CRVO 0.64
- MACD
- BGSF 0.15
- CRVO -0.29
- Stochastic Oscillator
- BGSF 47.73
- CRVO 0.96
About BGSF BGSF Inc.
BGSF Inc is a national provider of consulting, managed services, and professional workforce solutions. two segments: Property Management and Professional. In the Property Management segment is a provider of office and maintenance talent. The Professional segment provides IT professionals with expertise in SAP, Workday, Peoplesoft, Hyperion, Oracle, One Stream, cyber, project management, managed services, and other IT workforce solutions to client partners on a national basis. The group generates the majority of its revenue from the Professional segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.